Cytek Biosciences (CTKB) Change in Cash (2020 - 2026)

Cytek Biosciences' Change in Cash history runs 7 years deep, the most recent figure standing at -$25.2 million for Q1 2026.

• Quarterly Change in Cash fell 630.93% year-over-year to -$25.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$29.6 million (up 59.87% YoY) and the FY2025 annual result came in at -$7.9 million, up 88.54% from the prior year.
• Change in Cash was -$25.2 million for Q1 2026 at Cytek Biosciences, down from -$2.4 million in the prior quarter.
• Across five years, Change in Cash topped out at $32.1 million in Q3 2023 and bottomed at -$167.1 million in Q1 2023.
• A 5-year average of -$17.6 million and a median of -$3.4 million in 2025 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2023 — Change in Cash slumped 7812.22% — and 2024, when it surged 1132.59%.
• Cytek Biosciences' Change in Cash stood at -$42.0 million in 2022, then jumped by 109.52% to $4.0 million in 2023, then slumped by 1688.55% to -$63.6 million in 2024, then surged by 96.18% to -$2.4 million in 2025, then sank by 937.82% to -$25.2 million in 2026.
• Business Quant data shows CTKB's Change in Cash at -$25.2 million in Q1 2026, -$2.4 million in Q4 2025, and $17.8 million in Q3 2025.